Ezabenlimab Antibody
Ezabenlimab (BI-754091) is a humanized anti-PD-1 monoclonal antibody that blocks PD-1/PD-L1/PD-L2 interactions. It is utilized in immuno-oncology research to study its antitumor effects in advanced solid tumor models, demonstrating activity in both in vitro immune checkpoint blockade assays and in vivo tumor growth inhibition studies.
Product Specifications
Product Name Alternative
PD-L1, PDL1, PD1/PDL1, PD-1, PD1, BI754091, BI-754091
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
5.64 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.21 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2789206 1.0 µg DNA
NYNRIN sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 